...
首页> 外文期刊>Cardiovascular Drugs and Therapy >Postconditioning in Reperfusion Injury: A Status Report
【24h】

Postconditioning in Reperfusion Injury: A Status Report

机译:再灌注损伤中的后处理:状态报告

获取原文
获取原文并翻译 | 示例
           

摘要

Early reperfusion after an organ ischemia is essential to salvage tissue from eventual death. However, abundant evidence suggests that reperfusion also elicits pathophysiological changes responsible for additional tissue injury after restoration of blood flow. Postconditioning (Postcon) defined as rapid sequential intermittent interruption of blood flow applied during early moments of reperfusion has successfully shown to attenuate organ injury, including the heart, spinal cord, brain, kidney, liver, muscle, lung and intestines in the experimental setting. Clinical trials have also revealed the beneficial effect of Postcon on myocardial infarction in patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. Although there are some controversial issues regarding the efficacy of protection with Postcon in different animal models with comorbities, most preclinical studies have shown that Postcon is a potent intervention to reduce organ necrosis and apoptosis. Remote or pharmacological Postcon has emerged as alternatives in amelioration of cardiac reperfusion injury. This article will primarily discuss the existing literature regarding protection of Postcon on the heart, but there is a potential for future research into other organ systems to identify beneficial effects of Postcon on tissue reperfusion injury, particularly in patients undergoing surgical revascularization.
机译:器官缺血后的早期再灌注对于挽救最终死亡的组织至关重要。然而,大量证据表明,再灌注还引起血液恢复后引起额外组织损伤的病理生理变化。后调节(Postcon)定义为在再灌注的早期应用连续快速断续的血流中断,已成功地证明可以减轻器官损伤,包括实验环境中的心脏,脊髓,脑,肾,肝,肌肉,肺和肠。临床试验还显示了Postcon对接受经皮冠状动脉介入治疗或冠状动脉搭桥术的患者的心肌梗塞的有益作用。尽管在不同合并症的动物模型中,Postcon的保护功效存在一些争议性问题,但大多数临床前研究表明,Postcon是一种有效的干预措施,可以减少器官坏死和细胞凋亡。远程或药理学上的Postcon已成为缓解心脏再灌注损伤的替代方法。本文将主要讨论有关在心脏上保护Postcon的现有文献,但是有可能在其他器官系统中进行进一步的研究,以确定Postcon对组织再灌注损伤的有益作用,特别是在进行外科血管重建的患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号